[1] 付坤, 柳景华.成纤维细胞生长因子21:从生理作用到临床研究[J].中国循环杂志, 2014, 29 (4):309-311.[2] Itoh N, Ornitz DM.Fibroblast growth factors: from molecular evolution to roles in development, metabolism and disease [J].J Biochem, 2011, 149 (2): 121-130.[3] Smith R, Duguay A, Weiszmann J, et al.A novel approach to improve the function of FGF21 [J].Biol Drugs, 2013, 27 (2): 159-166.[4] 王会岩, 张耀方, 李校堃, 等.人成纤维细胞生长因子-21分泌型表达及鉴定[J].吉林农业大学学报, 2009, 31 (3): 255-257.[5] 刘敏, 李校堃, 王会岩, 等.成纤维细胞生长因子-21对体外诱导的非酒精性脂肪肝细胞模型脂代谢的影响[J].吉林大学学报:医学版, 2012, 38(3): 477-481.[6] Zhu WH, Wang CW, Wang HY, et al.Effects of fibroblast growth factor 21 on cell damage in vitro and atherosclerosis in vivo [J].CanJPhysiolPharmacol, 2014, 92 (11):927-935.[7] Fisher FM, Chui PC, Antonellis PJ, et al.Obesity is a fibroblast growth factor 21 (FGF21)-resistant state [J].Diabetes, 2010, 59 (11): 2781-2789.[8] Zhang J, Li Y.Fibroblast growth factor 21, the endocrine FGF pathway and novel treatments for metabolic syndrome [J].Drug Discov Today, 2014, 19 (5): 579-589.[9] 韩苗苗, 王文飞, 任桂萍, 等.FGF-21对H2O2诱导的大鼠心肌细胞H9c2氧化应激损伤的保护作用[J].药学学报, 2014, 49 (4): 470-475.[10] 杜娟, 陈汝贤.成纤维细胞生长因子21在动脉粥样硬化发病机制中的研究进展[J].中华临床医师杂志, 2014, 8(11):2099-2103.[11] 姚成灿, 郑青, 许华, 等.重组人酸性成纤维细胞生长因子的稳定性研究[J].中国现代应用药学杂志, 2006, 23 (5):358-360.[12] Wang HY, Xiao YC, Li XK, et al.High-level expression and purification of soluble recombinant FGF21 protein by SUMO fusion in Escherichia coli [J].BMC Biotechnol, 2010, 10 (1): 14-23.[13] Brian MB, Bernhardt LT.Rational design of solution additives for the prevention of protein aggregation [J].Biophys J, 2004, 87 (3): 1631-1639.[14] Song LT, Zhu YL, Huang ZF, et al.A solid-phase PEGylation strategy for protein therapeutics using a potent FGF21 analog [J].Biomaterials, 2014, 35 (3): 5206-5215.[15] Huang ZF, Ni C Y, Zhou X, et al.Mechanism of pH sensitive polymer-assisted protein refolding and it s application in TGF-beta and KGF-2 [J].Biotechnol Prog, 2009, 25 (5): 1387-1395.[16] 冯小黎, 金业涛, 苏志国.一个新的代谢调节因子-成纤维细胞生长因子 21[J].生物工程进展, 2000, 20 (3): 67-71. |